Ray Furey | EVP, General Counsel and Corporate Secretary. |
Raul Rodriguez | President and CEO |
Dave Santos | EVP and Chief Commercial Officer |
Dean Schorno | EVP and Chief Financial Officer |
Yigal Nochomovitz | Citigroup, Inc. |
Kristen Kluska | Cantor Fitzgerald & Co. |
Joseph Pantginis | H.C. Wainwright & Co. |
Eun Yang | Jefferies & Company |
Allison Bratzel | Piper Sandler & Co. |
Kalpit Patel | B. Riley Securities |
Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Second Quarter of 2023. At this time, all participants are in a listen only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce our first speaker, Ray Furey, Rigel's Executive Vice President, General Counsel and Corporate Secretary.